|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Net earned premiums, principally supplemental health insurance | |||||
| Net investment income | |||||
| Net investment gains (losses) | |||||
| Other income (loss) | |||||
| Total revenues | |||||
| Benefits and expenses: | |||||
| Benefits and claims, excluding reserve remeasurement | |||||
| Reserve remeasurement (gains) losses | |||||
| Total benefits and claims, net | |||||
| Acquisition and operating expenses: | |||||
| Amortization of deferred policy acquisition costs | |||||
| Insurance commissions | |||||
| Insurance and other expenses | |||||
| Interest expense | |||||
| Total acquisition and operating expenses | |||||
| Total benefits and expenses | |||||
| Earnings before income taxes | |||||
| Income tax expense (benefit): | |||||
| Current | |||||
| Deferred | |||||
| Income taxes | |||||
| Net earnings | |||||
| New earnings per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average outstanding common shares used in computing earnings per share (In thousands): | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Cash dividends per share |
Loading...